MedPath

ORPHENADRINE CITRATE

Approved
Approval ID

e506b8dc-36b3-44f2-9fd6-316233efeb8b

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 20, 2011

Manufacturers
FDA

STAT RX USA LLC

DUNS: 786036330

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ORPHENADRINE CITRATE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code16590-177
Application NumberANDA040368
Product Classification
M
Marketing Category
C73584
G
Generic Name
ORPHENADRINE CITRATE
Product Specifications
Route of AdministrationORAL
Effective DateApril 20, 2011
FDA Product Classification

INGREDIENTS (5)

ORPHENADRINE CITRATEActive
Quantity: 100 mg in 1 1
Code: X0A40N8I4S
Classification: ACTIB
POVIDONEInactive
Code: FZ989GH94E
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
ETHYLCELLULOSESInactive
Code: 7Z8S9VYZ4B
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ORPHENADRINE CITRATE - FDA Drug Approval Details